RE:RE:RE:RE:May have been posted before but interesting anywayIngiboy wrote: Yes psvb we are left to speculate about this long standing acrimony between the two companies. Thanks to new information on Shiseido Patents and the Contract between Replicel and Shiseido provided by Inv3strr we now have a clearer picture of what is really going on.
As the share price drifts downward each day at this critical time we hear nothing from the management of Replicel. Will we hear a detailed NR before the AGM or at the AGM? One way or another its time for the shareholders to hear a complete description of what is going on with Shiseido and the Dermal Injector.
It is evident that at the moment until we get the full description of what is happening with Shiseido and the Dermal Injector the company is going nowhere. It is painfully evident that some shareholders have lost faith in the future of this company and are dumping their shares.
The result is we are now trading at $.155 which I think may be a new all time low.
All companies need cash to survive, whether through revenue or sale of stock. Replicel is no where near generating revenue. Based on the rapidly dropping share price, I believe they can't raise the required cash to keep the company alive. There only option may be to put the company up for sale. If RCH01 was worth bringing to market Shiseido would have worked out a compromise. They don't have to release their trial data let alone share. Unless there is substantial news VERY soon, Replicel is dead in the water.